---
title: "Statistical Analysis Plan"
subtitle: "CT02 - Time-to-Event Endpoint Trial Analysis"
format: pdf
execute: 
  echo: false
  warning: false
---

## Objectives
Evaluate the effect of treatment on time-to-event outcomes within a randomized clinical trial setting.

## Analysis Population
Primary analysis will be conducted in the intention-to-treat (ITT) population, defined as all randomized subjects analyzed according to assigned treatment group.

## Primary Endpoint
Time from randomization to first occurrence of the clinical event, measured in days (time).
Subjects without an event will be censored at last known follow-up (status; 1=event, 0=censored).

## Primary Statistical Methods
The primary analysis will use a Cox proportional hazards regression model with treatment group as the primary predictor, adjusting for age, sex, and baseline severity.
Results will be reported as adjusted hazard ratios (HRs) with 95% confidence intervals and Wald p-values.
The Control group will serve as the reference category.

## Model Assumptions and Diagnostics
The proportional hazards assumption will be evaluated using Schoenfeld residuals.
Kaplanâ€“Meier survival curves will be generated by treatment group for descriptive and diagnostic purposes.
Influential observations will be assessed using dfbeta diagnostics.

## Secondary / Sensitivity Analyses
- Sensitivity analysis excluding baseline severity from the adjustment set.
- Exploratory treatment-by-baseline severity interaction model to assess effect modification.
- Hazard ratios will be estimated at representative baseline severity values (e.g., 40, 50, 60).

## Missing Data Handling
The primary analysis will use complete-case data for covariates included in the model.
Censoring will be assumed to be non-informative.

## Software
All analyses will be conducted in R using validated scripts.

